Semaglutide is a testament to scientific innovation, but continued, rigorous research is vital to maximize its full potential, ensure equitable access globally, and address all remaining questions for optimal patient care
The progression of semaglutide from a metabolic drug to a potential neuroprotective agent is ongoing, but its future role in neurology will likely focus on the prevention of neurodegeneration rather than the treatment of established diseases
The National Eating Disorders Association offers an online questionnaire to help people assess whether they are experiencing an eating disorder
FDA-Approved Uses For Diabetes, Obesity, And Related Conditions It's important to understand what each medication is officially approved for by the FDA
Yes, obesity is a health crisis
Lilly's SURPASS-1 Results Published in The Lancet Show Tirzepatide's Superior A1C and Body Weight Reductions Versus Placebo in Adults With Type 2 Diabetes